Answers are grounded in this paper and cite their sources.
UNLABELLED: The lack of availability of licensed paediatric medicines forces pharmacists to compound drugs into a form that children can tolerate. There is a lack of information to support much of this practice and standards tend to vary. Suitable licensed alternatives are often available in other countries but importing restrictions complicate obtaining them. CONCLUSION: Regulatory action is needed to simplify licensing and importation processes to facilitate universal access to suitable paediatric medicines.
No takes yet. Share an insight, caveat, or question.
Sharon Conroy (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: